Sensei Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	16	17	46	177	-	-	Upgrade
Market Cap Growth	-43.34%	-62.21%	-74.21%	-	-	-	Upgrade
Enterprise Value	-37	-42	-53	32	-16	15	Upgrade
PE Ratio	-	-0.51	-0.94	-4.82	-	-	Upgrade
PB Ratio	0.27	0.27	0.44	1.21	-	-	Upgrade
P/FCF Ratio	-0.95	-0.54	-1.16	-5.55	-	-	Upgrade
P/OCF Ratio	-0.94	-0.54	-1.17	-5.86	-	-	Upgrade
EV/EBITDA Ratio	0.90	1.35	1.16	-0.91	0.87	-1.07	Upgrade
EV/EBIT Ratio	0.82	1.24	1.10	-0.89	0.86	-1.06	Upgrade
EV/FCF Ratio	0.94	1.32	1.36	-1.01	0.84	-1.78	Upgrade
Debt / Equity Ratio	0.10	0.10	0.08	0.02	-0.01	-0.23	Upgrade
Debt / EBITDA Ratio	-0.19	-0.20	-0.18	-0.07	-0.04	-1.11	Upgrade
Debt / FCF Ratio	-0.20	-0.19	-0.20	-0.07	-0.04	-1.86	Upgrade
Quick Ratio	11.63	11.65	11.82	30.19	3.44	0.03	Upgrade
Current Ratio	12.07	11.92	11.98	30.38	4.16	0.02	Upgrade
Interest Coverage	-244.51	-235.81	-220.86	-53.92	-10.90	-6.42	Upgrade
Return on Equity (ROE)	-46.70%	-44.00%	-40.60%	-23.10%	32.30%	33.60%	Upgrade
Return on Assets (ROA)	-40.90%	-38.60%	-36.30%	-22.40%	-178.40%	-1339.70%	Upgrade
Return on Capital (ROIC)	-54.26%	-52.13%	-45.04%	-25.18%	34.88%	23.64%	Upgrade
Earnings Yield	-201.95%	-197.14%	-106.15%	-20.73%	-	-	Upgrade
FCF Yield	-175.99%	-185.21%	-85.93%	-18.01%	-	-	Upgrade
Buyback Yield / Dilution	18.85%	8.96%	-10.80%	-1618.88%	-338.85%	97.92%	Upgrade
Total Shareholder Return	18.85%	8.96%	-10.80%	-1618.88%	-338.85%	97.92%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).